A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

NCT00069888 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi